Author:Wirth, Timo Schulte-Mecklenbeck, Andreas Steinberg, Olgra Raposo, Catarina Groß, Catharina Wiendl, Heinz Klotz, Luisa
Session Name:S16: MS Clinical Trials and Therapeutics
Topic:MS and Inflammatory Disease
Program Number:S16.003
Author Institution:Department of Neurology with Institute of Translational Neurology, University Hospital of Münster, Westfälische-Wilhelms-University Münster, Münster, Germany, Munster, Germany F. Hoffmann-La Roche Ltd, Basel, Switzerland, Basel, Switzerland
Author:Wiendl, Heinz De Stefano, Nicola Barkhof, Frederik Montalban, Xavier Achiron, Anat Derfuss, Tobias Chan, Andrew Hodgkinson, Suzanne Prat, Alexandre Leocani, Letizia Schmierer, Klaus Sellebjerg, Finn Vermersch, Patrick Jin, Hulin Jarvinen, Elina Chudecka, Anita Gardner, Lidia
Session Name:S16: MS Clinical Trials and Therapeutics
Topic:MS and Inflammatory Disease
Program Number:S16.006
Author Institution:University of Muenster, Muenster, Germany Department of Medicine, Surgery and Neuroscience, University of Siena, Siena, Italy VU University Medical Center, Amsterdam, Netherlands Centre d’Esclerosi Múltiple de Catalunya (Cemcat), Hospital Universitario Vall d’Hebron, Universitat Autonoma de Barcelona, Barcelona, Spain Multiple Sclerosis Center, Sheba Academic Medical Center, Ramat Gan, Israel University Hospital Basel, Basel, Switzerland Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland Ingham Institute for Applied Medical Research, University of New South Wales Medicine, Sydney, Australia Université de Montréal, Montreal, QC, Canada Experimental Neurophysiology Unit, Vita-Salute San Raffaele University, Milan, Italy The Blizard Institute, Centre for Neuroscience, Surgery & Trauma, Barts and The London School of Medicine & Dentistry, Queen Mary University of London, London, United Kingdom Copenhagen University Hospital - Rigshospitalet, Glostrup, Denmark Inserm U1172 LilNCog, CHU Lille, FHU Precise, Lille, France the healthcare business of Merck KGaA, Darmstadt, Germany, Darmstadt, Germany Cytel Inc. Geneva, Switzerland, Geneva, Switzerland EMD Serono, Billerica, MA, USA, Billerica, MA
Author:Cohen, Jeffrey Hauser, Stephen Zielman, Ronald Das Gupta, Ayan Azmon, Amin Xi, Jing Mavrikis Cox, Gina Robertson, Derrick Wiendl, Heinz Kappos, Ludwig
Session Name:S16: MS Clinical Trials and Therapeutics
Topic:MS and Inflammatory Disease
Program Number:S16.009
Author Institution:Department of Neurology, Mellen MS Center, Neurological Institute, Cleveland Clinic, Cleveland, OH, USA, Cleveland, OH UCSF Weill Institute for Neurosciences, Department of Neurology, University of California - San Francisco, San Francisco, CA, USA, San Francisco, CA Central Texas Neurology Consultants, Round Rock, TX, USA, Round Rock, TX Novartis Pharma B.V., Amsterdam, The Netherlands, Haaksbergweg, Netherlands Novartis Healthcare Pvt. Ltd., Hyderabad, India, Hyderabad, India Novartis Pharma A.G., Basel, Switzerland, Basel, Switzerland China Novartis Institutes for BioMedical Research Co., Ltd, Shanghai, China, Shanghai, China, People's Republic of Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA, East Hanover, NJ Multiple Sclerosis Division, Department of Neurology, University of South Florida, Tampa, FL, USA, Tampa, FL University of Muenster, Muenster, Germany, Muenster, Germany Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB) and MS Center, Departments of Head, Spine and Neuromedicine, Clinical Research, Biomedicine and Biomedical Engineering, University Hospital and University of Basel, Basel, Switzerland, Basel, Switzerland
Author:Gross, Catharina C Schulte-Mecklenbeck, Andreas Steinberg, Olga V Wirth, Timo Lauks, Sarah Baranzini, Sergio E Bittner, Stefan Bellmann-Strobl, Judith Bünger, Nora Eilers, Eva Eveslage, Maria Fleischer, Vinzenz Gisevius, Barbara Groppa, Sergiu Haas, Jürgen Kerschensteiner, Martin Kirstein, Lucienne Korsukewitz, Catharina Lohmann, Lisa Lünemann, Jan Lüssi, Felix Meyer zu Hörste, Gerd Motte, Jeremias Ruck, Tobias Schwab, Nicholas Meuth, Sven G Paul, Friedemann Wildemann, Brigitte Kümpfel, Tania Gold, Ralf Zipp, Frauke Klotz, Luisa Wiendl, Heinz
Session Name:P1: MS Biomarkers
Topic:MS and Inflammatory Disease
Program Number:P1.008
Author Institution:University Hospital Münster, Münster, Germany University of California San Francisco, San Francisco, CA University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany Max Delbrueck Center for Molecular Medicine and Charité Universitätsmedizin Berlin, Berlin, Germany University of Münster, Münster, Germany University Hospital Bochum, Bochum, Germany University of Heidelberg, Heidelberg, Germany Ludwig Maximilians University of Munich, Munich, Germany University and University Hospital of Münster, Münster, Germany Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany Charite Universitatsmedizin in Berlin, Berlin, Germany University Hospital Heidelberg, Heidelberg, Germany
Author:Howard, James Li, George Vu, Tuan Korobko, Denis Smilowski, Marek Liu, Li Steeland, Sophie Noukens, Jan Van Hoorick, Benjamin Podhorna, Jana Li, Yuebing Utsugisawa, Kimiaki Sacca, Francesco Wiendl, Heinz De Bleecker, Jan Mantegazza, Renato ADAPT-SC Investigator Study Group, in collaboration with the
Session Name:P1: Autoimmune Neurology: Myasthenia Gravis
Topic:Autoimmune Neurology
Program Number:P1.014
Author Institution:The University of North Carolina, Chapel Hill, NC Medsol Clinical Research Center Inc, Port Charlotte, FL University of South Florida, Morsani College of Medicine, Tampa, FL State Budgetary Healthcare Institution of Novosibirsk Region "State Novosibirsk Regional Clinical Hospital", Novosibirsk, Russian Federation Medical University of Silesia, Katowice, Poland argenx, Ghent, Belgium Curare Consulting BV, Etten-Leur, Netherlands Cleveland Clinic, Cleveland, OH Hanamaki General Hospital, Hanamaki, Japan Federico II University of Naples, Napoli, Italy University of Münster, Münster, Germany Ghent University Hospital, Ghent, Belgium Fondazione Istituto Neurologico Carlo Besta, Milan, Italy N/A, Yardley, PA